
Hims Stock
Men's wellness brand
Sign up today and learn more about Hims Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Hims Stock
Hims is an e-commerce wellness brand made for men with products for skin care, erectile dysfunction, and hair loss. The company works with doctors to prescribe Finasteride and Sildenafil (active ingredient in Viagra) through the app or website. With a telemedicine approach, hims allows customers to get diagnosed and treated at a lower cost and with greater convenience. Hims was incubated at San Francisco-based venture-builder, Atomic. In November 2017, the company raised $7 million in Series A funding from Thrive Capital, Forerunner Ventures, M.C. Ventures, SV Angel, Amity Supply, and Harry’s. In June 2018, hims raised $50 million in Series B funding. Institutional Venture Partners led the round which included Forerunner Ventures, Thrive Capital, Maverick Capital, and Redpoint Ventures. Hims was founded in November 2017 after CEO Andrew Dudum was called out by his sister for having dry skin and breakouts. She ordered him a bunch of expensive products to help fix the issues and Dudum quickly realized that men didn’t have the same options as women when it came to purchasing wellness products. He set out to create a company that offered simple solutions for issues many guys face. In November 2017 hims was launched and nearly four months after it was reported that the company was worth $200 million.
Investors
8VC
Anduril Industries, Sila Nanotechnologies, Cityblock Health, project44, Blend, Aspiration, Addepar, Illumio, BlueVoyant, Guardant Health
Counterpart Advisors
Scopely, TripActions, Via, Convoy, project44, Deel, Getaround, Goat Group, StockX, Turo
Forerunner Ventures
Jet, Chime, Faire, Dollar Shave Club, Warby Parker, Hims, Glossier, Zola, Away, Curated
Founders Fund
Lyft, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass, Zenefits
Funding History
December 2013 | $11 |
---|---|
September 2017 | $753K |
September 2017 | $6.6M |
December 2017 | $24.6M |
January 2018 | $20.0M |
June 2018 | $51.4M |
February 2019 | $100M |
Management
Co-Founder & Chief Executive Officer
Andrew Dudum
Co-Founder & VP Product
Hilary Coles
Co-Founder
Jack Abraham
Chief Operating Officer
Melissa Baird
Chief Financial Officer
Spencer Lee
Press
TechCrunch - May, 20 2020
Hims & Hers launch Spanish language telemedicine servicesFast Company - May, 13 2020
Hims begins distributing COVID-19 saliva tests you can take at homeTechCrunch - Apr, 7 2020
Hims launches group therapy services as first foray into broader mental health initiativeTechCrunch - Feb, 5 2020
Foxtrot picks up $17 million to reimagine the convenience storephillyvoice - Jan, 24 2019
This brand condensed the world of men's health and wellness into one websitemenshealth - Jan, 24 2019
Can Hims' New Premature Ejaculation Spray Make Sex Last Longer?psfk - Jan, 19 2019
Interview: How Men's Healthcare Startup hims Enables Convenient And Affordable Treatmentqz - Mar, 12 2018
“Hims” is borrowing the Goop aesthetic to sell wellness to menFast Company - Nov, 15 2017
This Startup Is Rebranding Penis Pills And Hair Loss Treatments For MillennialsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase